Back to Trades
PAPADOPOULOS STELIOS
DirectorCIK 0001202098
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 2
- Active
- 2025–2026
Across 3 filings between 2025–2026, PAPADOPOULOS STELIOS, Director, has disclosed $4.4M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $4.4M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| May 29 | EXEL EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Grant | $0 |
| Apr 9 | OVID Ovid Therapeutics Inc. | PAPADOPOULOS STELIOS | Insider | Grant | $45.0K |
| Nov 13 | EXEL EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | $4.4M |
3 filings